Do you have Fatty Liver or NASH? Participate in a study

Enter your info and the study team will contact you soon!
Your data is securely stored and only shared with the research team
Please answer a few questions to see if you may qualify.
Have questions? Please contact the study coordinator Sandeep Dhaliwal at sandhaliwal@ucdavis.edu or call (916) 694-1662
By clicking "Next", you're consenting to participate in this questionnaire. There are no right or wrong answers and everything you enter is confidential.
  1. *1. Are you between 18 and 75 years (inclusive) old?
  2. 2. Are you male?
  3. *3. Have you been diagnosed with or are you at risk for fatty liver/NASH?
    Be overweight or obese, have diabetes or pre-diabetes, have abnormal levels of fat in blood
Logo Image
"We are evaluating a new investigational medicine for the treatment of NASH"
Age: 18 - 75 years
Gender:
Any
Healthy Volunteers: No
Keywords: NASH, Fatty liver, Nonalcoholic Steatohepatitis, RESOLVE-IT
Type: Phase 3, Drug study
Investigator:
Description
We're inviting people with fatty liver or nonalcoholic steatohepatitis (NASH) to participate in a research study. The goal of this study is to see if an investigational medicine called Elafibranor is safe and effective for the treatment of NASH.

Nonalcoholic steatohepatitis or NASH is a liver disease that is affecting millions of Americans. It is marked by liver inflammation and damage caused by a buildup of an unhealthy amount of fat in the liver. NASH may progress to scarring and lasting damage to the liver. Currently, no FDA approved medications are available.

You will receive study medication and study evaluations at no cost, and compensation for your time is available. Experienced clinicians at the UC Davis Department of Gastroenterology and Hepatology will take care of all study participants.
This study requires

This study will last up to 6 years. If eligible, the study involves three phases:

  • Screening phase: up to 2 visits to the study center
  • Treatment phase: 7 study visits over a period of 72 weeks
  • Long term treatment phase: study visits approximately every 6 months until the end of study
Who can participate
  • Be between 18 and 75 years (inclusive) old
  • Have fatty liver or NASH

Who CANNOT Participate:

  • Pregnant or planning a pregnancy
Compensation
You will receive $60.00 for each study visit completed. If you discontinue early from the study, you will receive a partial amount based on how many study visits you completed.
Resources
Schedule
Study duration and period
Your participation will last 6 years.
Location
UC Davis Medical Center
2000 Stockton Boulevard
Suite 100
Sacramento, CA 95817
Contact
Sandeep Dhaliwal

Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.


Sending

Send SMS with Study Info:

SMS Sent!

Share Study Info via Email:


E-mail Preview